Stephen Huhn
Direttore Tecnico/Scientifico/R&S presso CONTINEUM THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Stephen Huhn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2020 | - |
Storia della carriera di Stephen Huhn
Precedenti posizioni note di Stephen Huhn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Direttore Tecnico/Scientifico/R&S | 17/06/2014 | 01/01/2016 |
| Corporate Officer/Principal | 01/01/2007 | 17/06/2014 | |
| Stanford University | Corporate Officer/Principal | - | - |
Formazione di Stephen Huhn
| University of Arizona | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
- Borsa valori
- Insiders
- Stephen Huhn
- Esperienza
